216 related articles for article (PubMed ID: 36484005)
1. Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1/lipoic acid pathway activation.
Nie X; Chen H; Xiong Y; Chen J; Liu T
J Cancer; 2022; 13(14):3503-3514. PubMed ID: 36484005
[TBL] [Abstract][Full Text] [Related]
2. Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways.
Xiong Y; Liu T; Chen J
J Cancer; 2023; 14(7):1202-1215. PubMed ID: 37215446
[TBL] [Abstract][Full Text] [Related]
3. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.
Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy.
Yang X; Zhang X; Shen K; Wang Z; Liu G; Huang K; He Z; Li Y; Hou Z; Lv S; Zhang C; Yang H; Liu S; Ke Y
Front Pharmacol; 2023; 14():1033859. PubMed ID: 37435496
[No Abstract] [Full Text] [Related]
5. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
Zhou C; Li C; Zheng Y; Huang X
Front Oncol; 2022; 12():934076. PubMed ID: 36387247
[TBL] [Abstract][Full Text] [Related]
6. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer.
Yang W; Wang Y; Huang Y; Yu J; Wang T; Li C; Yang L; Zhang P; Shi L; Yin Y; Tao K; Li R
Biomed Pharmacother; 2023 Mar; 159():114301. PubMed ID: 36706634
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
Front Genet; 2022; 13():939956. PubMed ID: 36105090
[No Abstract] [Full Text] [Related]
8. Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion.
Chen Q; Liu X; Xu L; Wang Y; Wang S; Li Q; Huang Y; Liu T
Oncol Rep; 2016 Apr; 35(4):1916-24. PubMed ID: 26783004
[TBL] [Abstract][Full Text] [Related]
9. Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease.
Wu C; Liu X; Zhong L; Zhou Y; Long L; Yi T; Chen S; Li Y; Chen Y; Shen L; Zeng Q; Tang S
Oxid Med Cell Longev; 2023; 2023():9245667. PubMed ID: 36865349
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis is involved in decabromodiphenyl ether-induced ovarian dysfunction and the protective effect of melatonin.
Wang Z; Zhang W; Huang D; Kang H; Wang J; Liu Z; Jiang G; Gao A
Environ Pollut; 2024 May; 352():124100. PubMed ID: 38714232
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer profiles of the cuproptosis gene set.
Liu H
Am J Cancer Res; 2022; 12(8):4074-4081. PubMed ID: 36119826
[TBL] [Abstract][Full Text] [Related]
12. Identification of cuproptosis-related genes for predicting the development of prostate cancer.
Wang X; Chen X; Xu C; Zhou W; Wu D
Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156
[TBL] [Abstract][Full Text] [Related]
13. Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis.
Li G; Peng L; Wu M; Zhao Y; Cheng Z; Li G
Front Immunol; 2022; 13():1039510. PubMed ID: 36601107
[TBL] [Abstract][Full Text] [Related]
14. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis.
Zhao X; Chen J; Yin S; Shi J; Zheng M; He C; Meng H; Han Y; Han J; Guo J; Yuan Z; Wang Y
Front Oncol; 2022; 12():992468. PubMed ID: 36313717
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
Chen Y
Front Genet; 2022; 13():912037. PubMed ID: 35937995
[No Abstract] [Full Text] [Related]
16. Investigating hub genes in the relationship between septic cardiomyopathy and cuproptosis and potential Chinese herbal drug candidates with bioinformatic tools.
Pang G; Hu K; Ji J; Xiong B; Han L; Pang J; Xiang S
Minerva Cardiol Angiol; 2024 May; ():. PubMed ID: 38804624
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma.
Wang S; Xing N; Meng X; Xiang L; Zhang Y
Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
Liu H; Tang T
Front Oncol; 2022; 12():952290. PubMed ID: 36276096
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-Related Gene FDX1 Identified as a Potential Target for Human Ovarian Aging.
Wu CC; Li CJ; Lin LT; Lin PH; Wen ZH; Cheng JT; Tsui KH
Reprod Sci; 2024 Apr; ():. PubMed ID: 38689081
[TBL] [Abstract][Full Text] [Related]
20. Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis.
Ye W; Ni Z; Yicheng S; Pan H; Huang Y; Xiong Y; Liu T
Int J Oncol; 2019 Dec; 55(6):1296-1312. PubMed ID: 31638182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
